Search all trials

Find therapies in clinical trials near you – page 5

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Asthma

Recruiting

Investigational

Study of PF-07275315 to evaluate its effectiveness and safety in adults with moderate-to-severe asthma who have high levels of eosinophils in their blood

Investigational

Italy

Participants:18–64 years · 65+ years

Contact Research Centre

Transitional cell carcinoma

Recruiting

Registered drugNo placebo

Study of datopotamab deruxtecan with platinum-based therapy compared to gemcitabine with platinum-based therapy in patients with advanced urothelial cancer after prior treatment

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Triple negative breast cancer+2

Recruiting

Registered drugNo placebo

Study on Atorvastatin's Role in Enhancing Immunotherapy for Patients with Triple Negative Breast Cancer and Non-Small Cell Lung Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Atorvastatin

Contact Research Centre

Non-small cell lung cancer

Recruiting

Registered drugNo placebo

Study of Sigvotatug Vedotin and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with High PD-L1 Levels

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Non-small cell lung cancer metastatic

Recruiting

Registered drug

Study of Adagrasib with Pembrolizumab and Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Adagrasib

Contact Research Centre

Chronic inflammatory demyelinating polyradiculoneuropathy

Recruiting

Registered drugNo placebo

Comparison of TAK-881 and HyQvia for adults with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Human Normal Immunoglobulin

Contact Research Centre

Sickle cell disease

Recruiting

Investigational

Study on Rilzabrutinib for Patients Aged 10-65 with Sickle Cell Disease

Investigational

Italy

Participants:0–17 years · 18–64 years
Substances:Rilzabrutinib

Contact Research Centre

Non-small cell lung cancer+3

Recruiting

Registered drugNo placebo

Study of ABBV-400 and Budigalimab for Adults with Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Budigalimab

Contact Research Centre

Sickle cell disease

Recruiting

Investigational

Study on How Well Etavopivat Works for Adolescents and Adults with Sickle Cell Disease

Investigational

Italy

Participants:0–17 years · 18–64 years · 65+ years
Substances:Etavopivat

Contact Research Centre

Acute myeloid leukaemia

Recruiting

Registered drugNo placebo

Study of gemtuzumab ozogamicin with chemotherapy for adults aged 18-60 with newly diagnosed favorable-intermediate-risk acute myeloid leukemia

Registered drugNo placebo

Italy

Participants:18–64 years
Substances:Busulfan

Contact Research Centre

Neoplasm+1

Recruiting

InvestigationalNo placebo

Study on the Safety and Effects of VERT-002 for Patients with Advanced Solid Tumors, Including Lung Cancer with MET Alterations

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:VERT-002

Contact Research Centre

Pleural mesothelioma malignant

Recruiting

Registered drug

Study on Atezolizumab for Patients with Malignant Pleural Mesothelioma After Surgery

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Find therapies in clinical trials near you – page 5

213 trials match your criteria

Asthma

Study of PF-07275315 to evaluate its effectiveness and safety in adults with moderate-to-severe asthma who have high levels of eosinophils in their blood

Transitional cell carcinoma

Study of datopotamab deruxtecan with platinum-based therapy compared to gemcitabine with platinum-based therapy in patients with advanced urothelial cancer after prior treatment

Triple negative breast cancer+2

Study on Atorvastatin's Role in Enhancing Immunotherapy for Patients with Triple Negative Breast Cancer and Non-Small Cell Lung Cancer

Non-small cell lung cancer

Study of Sigvotatug Vedotin and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with High PD-L1 Levels

Non-small cell lung cancer metastatic

Study of Adagrasib with Pembrolizumab and Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation

Chronic inflammatory demyelinating polyradiculoneuropathy

Comparison of TAK-881 and HyQvia for adults with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)

Sickle cell disease

Study on Rilzabrutinib for Patients Aged 10-65 with Sickle Cell Disease

Non-small cell lung cancer+3

Study of ABBV-400 and Budigalimab for Adults with Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Sickle cell disease

Study on How Well Etavopivat Works for Adolescents and Adults with Sickle Cell Disease

Acute myeloid leukaemia

Study of gemtuzumab ozogamicin with chemotherapy for adults aged 18-60 with newly diagnosed favorable-intermediate-risk acute myeloid leukemia

Neoplasm+1

Study on the Safety and Effects of VERT-002 for Patients with Advanced Solid Tumors, Including Lung Cancer with MET Alterations

Pleural mesothelioma malignant

Study on Atezolizumab for Patients with Malignant Pleural Mesothelioma After Surgery

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.